| Pharmaceutical active ingredients: |
| GlycerolHypromelloseMacrogol 400 |
| Available forms, composition and doses of Visine Tears: |
| N / A |
| Visine Tears medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01XA20 - Artificial Tears and other indifferent preparations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pfizer |
| Related documents and information about Visine Tears: |
| Visine-A prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Visine Moisturizing | Macrogol 400; Tetrahydrozoline Hydrochloride | Pfizer |
| Visine Original | Tetrahydrozoline Hydrochloride | Pfizer; Johnson & Johnson |
| Visine Pure Tears | Glycerol; Hypromellose; Macrogol 400 | Pfizer |
| Visine Refresh | Glycerol; Hydroxypropyl Methylcellulose; PEG-400 | Johnson & Johnson; Zuellig Pharma |
| Visine Revive | Macrogol 400; Tetrahydrozoline Hydrochloride | Pfizer |
| Visine True Tears | Polyethylene Glycol 400 | Pfizer |
| Visine Workplace | Oxymetazoline Hydrochloride | Pfizer; Johnson & Johnson |
| Visine-A | Naphazoline Hydrochloride; Pheniramine Maleate | Pfizer |
| Visiodose | Chlorhexidine Gluconate; Phenylephrine Hydrochloride | Cooperation Pharmaceutique Francaise |
| Visioglobina | Ocular Antisera Equine | GlaxoSmithKline |